HRT Financial’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,371
| Closed | -$884K | – | 3236 |
|
|
2025
Q1 | $884K | Buy |
49,371
+34,966
| +243% | +$626K | 0.01% | 999 |
|
|
2024
Q4 | $250K | Sell |
14,405
-93,087
| -87% | -$1.62M | ﹤0.01% | 1614 |
|
|
2024
Q3 | $1.5M | Buy |
107,492
+16,028
| +18% | +$224K | 0.01% | 944 |
|
|
2024
Q2 | $751K | Buy |
+91,464
| New | +$751K | ﹤0.01% | 1042 |
|
|
2024
Q1 | – | Sell |
-148,943
| Closed | -$1.34M | – | 2927 |
|
|
2023
Q4 | $1.34M | Buy |
148,943
+33,626
| +29% | +$302K | 0.01% | 793 |
|
|
2023
Q3 | $1.03M | Buy |
+115,317
| New | +$1.03M | 0.01% | 865 |
|
|
2023
Q2 | – | Sell |
-17,909
| Closed | -$402K | – | 3075 |
|
|
2023
Q1 | $402K | Buy |
+17,909
| New | +$402K | ﹤0.01% | 1421 |
|
|
2022
Q2 | – | Sell |
-74,002
| Closed | -$1.91M | – | 3542 |
|
|
2022
Q1 | $1.91M | Buy |
+74,002
| New | +$1.91M | 0.01% | 599 |
|
|
2021
Q4 | – | Sell |
-72,215
| Closed | -$1.75M | – | 3769 |
|
|
2021
Q3 | $1.75M | Buy |
+72,215
| New | +$1.75M | 0.01% | 742 |
|
|
2020
Q1 | – | Sell |
-16,595
| Closed | -$235K | – | 1249 |
|
|
2019
Q4 | $235K | Buy |
+16,595
| New | +$235K | 0.01% | 818 |
|